top of page

Well-established medical cannabis importer, exporter & distributor in Germany seeks equity partner

German medical cannabis distributor with sales network into German pharmacies & global markets seeks a strategic partner to invest €3-5 million for a substantial ownership position, & to fuel expansion plans. Projecting €5 million revenue in 2024!

Listing ID:

10196465022

Licence(s) Held:

Narcotics Licence, GDP Distribution Licence

10196465022

Seeking strategic equity partner to fund continued growth

Listing Details:

  • Licensed German medical cannabis wholesaler importing, exporting & distributing a range of medicinal cannabis product forms selling in Germany, as well as other global markets

  • Currently conducting import and distribution of dried flower, extracts, finished medical cannabis products and API in bulk and jars. Also providing in-house branding and white labelling services, B2B and B2C sales

  • Operating from licensed, leased premises in a commercial building, incorporating offices and lab space to support imports, as well as an EU-GMP partner processing and storage facility

  • Experienced, industry-leading team with deep expertise navigating German, European and global medical cannabis markets, with a firm grasp on the recreational cannabis market opportunity in Germany and the rest of Europe

  • Company has differentiated digital infrastructure and online assets providing significant competitive advantage

  • Working with an increasing number of suppliers as a “launch pad” into the German market, via white-label packaging, distribution and market access services

  • Business is lean and efficient, operating at a low monthly burn rate with low debts

  • Identified as one of the Top 20 Cannabis Distributors in Germany

  • The Company is highly involved and up-to-date with the legal proposals for cannabis legalization in Germany

  • Company is at break-even in 2022 and 2023 and is forecasting imminent cash flow positive status with ~€5 million projected annual sales in 2024

  • Company is well-equipped with contracts for the European cannabis industry surge set to commence in 2024

  • Company can also perform research on psychedelics under the existing licences

  • Looking for a strategic partner or a merger to build on its unique platform, further scaling commercial operations and expanding to meet clientele demands in Europe

10196465022

Inquiry Form

Thanks for submitting! We have received your message and will get back to you within 24 hours. Until then, you can send an email to info@hydeadvisory.com

Contact-us-deal
bottom of page